Anhui Lianchuang Biological Medicine Co., Ltd ( hereinafter referred to as "The Company" ), was established in 2009 and headquartered in the west of Fanhua Avenue, Hefei Economic and Technological Development Zone. The company is a national high-tech enterprise with the mission of serving health and pursuing technical contribution. It is an innovative technology company providing products and technical services to consumers and global pharmaceutical manufacturers.

The company's current main business is pharmaceutical APIs and characteristic intermediates.

The company has several subsidiaries, which are engaged in the R&D and production of pharmaceutical APIs and intermediates, preparations MAH, diabetes control devices and food development, etc.

After years of development, the company has gathered a group of professional scientific experts and business backbone, specializing in the field of organic synthesis and enzymatic synthesis of pharmaceutical products. Nowadays, the company has more than 20 independent innovation invention patents, and has provided products and technical support for nearly 100 enterprises worldwide, forming a product line with diabetes control drugs as the core and other complementary products.

The company always advocates innovation and sharing drive in parallel -- in innovation development, the company implements active and flexible business model and differentiated product selection; in operation strategy, the company insists on the principle of maximizing corporate value, making the company a platform for customers and employees to discuss, share, build and win together.

Anhui Lianchuang Biological Medicine Co., Ltd will not forget its original intention, run true to form, to promote technological innovation and contribute to building a healthy China.